Podcasts about wegovy

Sky-high insurance premiums. Surprise medical bills. Drug prices that keep going up. Why does healthcare in America cost so much — and how did we end up here? Dr. Cedric Jamie Rutland, a critical care physician and BuzzRx Medical Advisor, joins Mosheh for a wide-ranging conversation that breaks down the real reasons healthcare is so expensive in the U.S. They explore how pharmacy benefit managers quietly shape what you pay, the unintended consequences of the Affordable Care Act, and why insurance coverage often feels arbitrary. Then, a deep dive into GLP-1 drugs like Ozempic and Wegovy: how they work, what they actually do to your body, and whether they're the future of weight loss and preventative care. Dr. Rutland also shares why having insurance — even if you're healthy — still matters more than many realize. BuzzRx, a prescription drug discount card and app service, saves users hundreds of dollars each month and has partnered with Mo News for a series focused on America's health and the prescription drug industry. Mo News Special: BuzzRx is offering the Mo News community up to $5 off your first prescription fill at BuzzRx.com/MoNews

The Trump administration regard many of the US's most prestigious universities as hotbeds of antisemitism and left-wing ideology. In addition to threatening to remove millions of dollars in funding the State Department has now issued a ban to American embassies around the world to stop holding student visa appointments. Social media vetting is also expected to be introduced for prospective students from abroad.Also on the programme: the V&A museum in London is giving the public the opportunity to choose which objects they want to see at the brand-new East Storehouse, a site that combines storage space with art exhibitions. And; about 2.5 billion people around the world are overweight. Weight-loss drugs such as Wegovy have made it easier for people to lose the extra kilos, but how safe are these drugs? Former commissioner for the U.S. Food and Drug Administration, Dr David Kessler, visits the studio to discuss our relationship with food.(Photo: A supporter with a sign reading 'We Love Our International Students,' arrives to a rally in support of the international student population at Harvard and other US Universities, outside the Science Center on the Harvard University campus in Cambridge, Massachusetts, USA, 27 May 2025. Credit: CJ GUNTHER/EPA-EFE/Shutterstock)

2025 Podcast Content Survey–I'd love to hear from you!! Everyone that participates will be entered into a drawing for an Amazon gift card! Drawing will be May 28 on instagram stories! Thanks!!GLP-1 medications like Ozempic and Wegovy have become more common—but the shame and secrecy around using them haven't gone away. In this episode, I'm talking about why these medications are not cheating, why I've chosen to include support for GLP-1 use in my coaching practice, and how they can be a helpful tool for some women—especially when paired with intentional, thoughtful behavior change.Whether you're using these medications now, considering them, or just curious about how coaching fits in, this episode will give you clarity, compassion, and maybe even some relief.What You'll Learn:Why using GLP-1s doesn't mean you've failed or taken the “easy way out”What these medications actually do—and what they don't fixHow I support clients on GLP-1s with emotional eating, habit change, and long-term planningWhat “bio-individuality” means and why it matters in your weight loss journeyWhy coaching is still valuable even when medication is part of the pictureSTART HERE: Download my FREE GLP-1 Success Starter KitLet's talk about whether support for GLP-1 use is right for you—book a free consult HEREMore from Well with Lisa:What To Do When You Overeat–During Weight Loss!  GRAB the free video mini-course! Normally $49– Free for podcast listeners!Your Go-To Meal Guide: grab it HEREReady for your free consult session?  SCHEDULE HERE!Let's be friends! Follow me on instagram:  @well_with_lisaMixhers! use Lisa10 to stack my discount with the current sale!Did you know  my listeners are entitled to 10% discount on a fullscript account? Get your Fullscript account HERE10% discount! (pssst: my clients get 25% for life!)Just to be clear: these are NOT weight loss supplements. This is an opportunity to get practitioner grade supplements like magnesium and omega oils at a little discount. yay!

In December 2017, the FDA approved a new injectable drug to treat type 2 diabetes called semaglutide, which you likely know by its brand name: Ozempic. A few years later, during the pandemic, Wegovy, a drug with a higher dose of the same active ingredient, was approved specifically for chronic weight management. Soon after, people taking Ozempic started reporting a dramatic, even “life-changing” weight loss. Ozempic is now a bona fide blockbuster. So what's the science behind these “wonder drugs” that apparently 1 in 10 of us could end up using? They have the potential to have so many positive effects on our lives, from treating Alzheimer's disease and addiction to changing our relationship with consumption but, like with most things, they also come with risks.Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Links to the Tiny Show and Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send me a text! I'd LOVE to hear your feedback on this episode!Important Links:Get in touch with Dr. Mark and his team here:https://sherwood.tv/Join my Substack here:   https://substack.com/@sandyknutrition?utm_source=user-menuDr. Mark Sherwood shares his journey from law enforcement to naturopathic medicine, exploring how personalized wellness approaches yield better results than one-size-fits-all health trends. Together we examine popular wellness practices, distinguishing between beneficial protocols and potentially harmful fads while emphasizing the importance of balance over extremes.• Dr. Mark's career transition from 20-year police veteran to naturopathic doctor after discovering the surprisingly short lifespan of law enforcement personnel• Why intermittent fasting affects women differently than men, particularly during perimenopause when hormonal changes already stress the body• How GLP-1 medications (Ozempic, Wegovy) can be beneficial when used properly as "training wheels" rather than quick weight loss solutions• The danger of focusing on weight loss rather than body composition, leading to muscle wasting and nutritional deficiencies• Why vegan diets often lack essential nutrients like omega-3, complete proteins, iron and B12 despite being promoted as optimal• The importance of "rhythm not robotic" living - finding non-negotiable health practices that still allow flexibility• How genetic factors determine whether practices like cold plunges are beneficial or harmful for specific individuals• Cautions about psychedelics and other brain-altering substances despite potential therapeutic applications• The value of writing practice with the prompt: "What does my soul want me to know today?"Be sure to follow Sandy K Nutrition, rate it, review it and share it. Always remember my friends, balanced living works.Support the showPlease rate & review my podcast with a few kind words on Apple or Spotify. Subscribe wherever you listen, share this episode with a friend, and follow me below. This truly gives back & helps me keep bringing amazing guests & topics every week.Instagram: https://www.instagram.com/sandyknutrition/Facebook Page: https://www.facebook.com/sandyknutritionTikTok: https://www.tiktok.com/@sandyknutritionYouTube: https://www.youtube.com/channel/UCIh48ov-SgbSUXsVeLL2qAgRumble: https://rumble.com/c/c-5461001Linkedin: https://www.linkedin.com/in/sandyknutrition/Substack: https://sandykruse.substack.com/Podcast Website: https://sandykruse.ca

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)Ever lost a lot of weight like 40, 50 pounds or more and noticed some unexpected changes in your body?In today's episode, we're talking about the surprising (and sometimes downright weird) side effects that don't get mentioned much when it comes to major weight loss—whether it's from lifestyle changes or medications like Zepbound or Wegovy.For example, some people develop Eustachian tube dysfunction, which can make your ears feel blocked or pop unexpectedly. Sitting might even feel uncomfortable now that the fat cushioning your tailbone is gone.Then there's “slimmer's paralysis”—a temporary nerve irritation that can pop up when the fat around certain nerves disappears. You might also spot new lumps or bumps, or find yourself feeling colder than usual since fat helps keep you warm.Other changes can include lower blood pressure and shifts in your menstrual cycle as your body adjusts.Want to hear more about these lesser-known effects and how to deal with them? Tune in to the full episode!Connect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com

✨ My GLP-1 Girlie group program is opening again at the end of February for enrollment for a 3/2/25 start date.

Many women in midlife are discovering that GLP-1 medications like Ozempic and Wegovy have been game-changers for improving metabolic health—but what happens when these medications become unavailable or too expensive? I'm excited to share five powerful, science-backed alternatives that can help you naturally stimulate GLP-1 production in your body without prescriptions. From the surprising benefits of a rare sugar called allulose that mimics GLP-1 effects without spiking insulin, to a New Zealand hops extract that raises GLP-1 levels for four hours after ingestion, these alternatives offer real solutions for women looking to maintain their fat loss progress and metabolic healing. We also dive into how specific probiotics, the protein-fiber combination, and berberine can naturally boost your body's GLP-1 production while addressing underlying metabolic issues that contribute to weight gain in our 40s and beyond.   What you'll learn: Why GLP-1 medications work so effectively and how they impact your metabolic health How Allulose, a rare sugar, naturally stimulates GLP-1 secretion without raising blood sugar or insulin The power of a specialized hops extract that can keep GLP-1 elevated for four hours Which specific probiotic strain boosts GLP-1 production and improves gut health How combining protein and fiber creates a one-two punch for natural GLP-1 stimulation The science behind berberine as "nature's Ozempic" for blood sugar and appetite regulation Essential lifestyle factors that maximize results when using GLP-1 alternatives Love the Podcast? Here's what to do: Make My Day & Share Your Thoughts! Subscribe to the podcast & leave me a review Text a screenshot to 813-565-2627 Expect a personal reply because your voice is so important to me. Join 55,000+ followers who make this podcast thrive. Want to listen to the show completely ad-free?  Go to subscribetojj.com Enjoy the VIP experience for just $4.99/month or $49.99/year (save 17%!) Click “TRY FREE” and start your ad-free journey today! Full show notes (including all links mentioned): https://jjvirgin.com/GLP1Alternatives Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Quah (Q & A), Sal, Adam & Justin coach four Pump Heads via Zoom. Mind Pump Fit Tip: The 5 MOST effective ways to achieve a calorie deficit. (2:11) The Mind Pump Butcher Box is here! (25:43) The power of the placebo effect. (28:26) I want to believe. (34:37) The most motivating thing you can see in the gym. (37:24) Are you retired? (39:38) Baby AI. (45:54) Social contagion is a REAL thing. (47:31) The positive feedback loop of Brain.fm. (49:59) #ListenerLive question #1 – Why would I need to change up my workout? (54:26) #ListenerLive question #2 – When do you know if your cut is not working? (1:01:08) #ListenerLive question #3 – Why would more movement and lower calorie intake cause a stall and an increase? (1:12:30) #ListenerLive question #4 – How can I get calories in when I don't have the appetite? (1:25:19) Related Links/Products Mentioned Ask a question to Mind Pump, live! Email: live@mindpumpmedia.com Visit Butcher Box for this month's exclusive Mind Pump offer!  ** For a limited time, new Butcher Box members who sign up through Mind Pump will receive: $20 OFF their first box, free chicken breast, ground beef, OR salmon in every box for a whole year! A curated box pre-filled with Mind Pump's favorite cuts — no guesswork, just great meat. ** Visit Brain.fm for an exclusive offer for Mind Pump listeners. ** Get 30 days of free access to science-backed music. ** Train the Trainer Webinar Series May Special: MAPS 15 Performance or RGB Bundle 50% off! ** Code MAY50 at checkout ** Mind Pump # 2437: What Happens to Your Body When You Quit Ultra-Processed Foods for 30 Days Mind Pump Group Coaching The Problem of Placebo Responses in Clinical Trials Mind Movies - Positive Daily Affirmations & Digital Vision Boards Visit Seed for an exclusive offer for Mind Pump listeners! **Promo code 25MINDPUMP at checkout for 25% off your first month's supply of Seed's DS-01® Daily Synbiotic** Mind Pump #2312: Five Steps to Bounce Back From Overtraining Mind Pump #2210: Best Workouts for Bulking & Cutting Mind Pump #2287: Bodybuilding 101- How to Bulk and Cut Mind Pump #2597: Before You Take Ozempic, Wegovy, or Mounjaro Listen to This! Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Josh Nickerson (@mindpumpjosh) Instagram Tom Bilyeu (@tombilyeu)  Instagram Bret Contreras PhD (@bretcontreras1) Instagram  

Do you obsess about food all the time? Or think about your next meal before you've even finished the one you're eating? This has a name: Food Noise. And it's exhausting. Despite what some jackasses out there say, food noise is very real. You're not broken or alone if it's driving you crazy. Today I'm going to tell you exactly "How to Stop Food Noise (with and without GLP-1's)." (GLP-1s are weightloss medications like Ozempic and Wegovy.) Listen to the episode to understand: What's causing your constant food thoughts Why certain foods can crank up your food noise Simple ways to quiet the chatter - with or without GLP-1's The emotional triggers that turn up the volume on your food noise Believe it or not, food noise is NOT the problem. It's simply a messenger trying to tell you something important. Ready to understand what it's saying so you can break free? Listen now. You shouldn't have to spend all day fighting with your own brain about food. Let me show you how to make peace instead. Get the Free Course here: http://NoBSFreeCourse.com

Are you struggling to lose weight with hypothyroidism or Hashimoto's—even when you're doing everything right?In this episode of My Thyroid Health, we take a deep dive into two powerhouse supplements: NAD+ and glutathione. These cellular-level nutrients are best known for their anti-aging and detoxifying effects, but they may also play a key role in boosting energy, improving thyroid function, and supporting weight loss—especially for thyroid patients.We also explore how combining NAD+ and glutathione with GLP-1 medications like Ozempic, Wegovy, or Mounjaro could enhance results for those struggling with metabolic resistance due to hypothyroidism. But is it safe? And what do thyroid patients need to know before starting?If you've been searching for new solutions to help with fatigue, inflammation, or a slow metabolism, this is the episode for you.Need more information? Learn more at the Paloma Health blog:Glutathione Benefits for Better Thyroid Healthhttps://www.palomahealth.com/learn/glutathione-benefits-thyroid-health The Health Benefits of NAD+https://www.palomahealth.com/learn/health-benefits-nad About Paloma Health:⁠⁠Paloma Health ⁠⁠⁠⁠⁠⁠⁠⁠is an online medical practice focused exclusively on treating hypothyroidism. From online visits with your provider to easy prescription management and lab orders, we create personalized treatment plans for you. Become a member⁠, or try our at-home test kit and experience a whole new level of hypothyroid care. Use code PODCAST to save $30 at checkout.Disclaimer: The $30 discount is only valid for first-time Paloma Health members and test kit users. Coupon must be entered at the time of checkout. Become a Paloma Member:https://www.palomahealth.com/pricing-hypothyroidism Paloma Complete Thyroid Blood Test Kit:https://www.palomahealth.com/home-thyroid-blood-test-kit

Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica Mendoza hosts.  Further Listening: Trillion Dollar Shot  Why WeightWatchers Wants in on Drugs Like Ozempic   Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

We all know the big economic stories of the year: the trade war, the tariffs. But there's another — even bigger? — story that hasn't been getting the same attention: the Ozempicification of our diets, our bodies and our economy. On this week's TLDR, we take a look at the transformation underway. Plus, economic indicators are telling one story about a potential recession; the headlines are telling another. Which one is right? And, why does it feel like everyone's drinking less alcohol? This episode was hosted by Devin Friedman, business reporter Sarah Rieger and former hedgefunder Matthew Karasz, with an appearance by Armine Yanizyan, Atkinson Fellow on the Future of Workers. Follow us on other platforms, or subscribe to our weekly newsletter: linkin.bio/tldrThe TLDR Podcast is offered by Wealthsimple Media Inc. and is for informational purposes only. The content in the TLDR Podcast is not investment advice, a recommendation to buy or sell assets or securities, and does not represent the views of Wealthsimple Financial Corp or any of its other subsidiaries or affiliates. Wealthsimple Media Inc. does not endorse any third-party views referenced in this content. More information at wealthsimple.com/tldr.

I'm not here to bash weight loss meds. But I am here to say the quiet part out loud. In this episode, I'm pulling back the curtain on GLP-1s like Ozempic, Wegovy, and Mounjaro—and telling you what most “experts” are too scared to say.   This isn't about judgment. I've been there. I've popped pills and prayed they'd shrink me into someone I could finally love. But here's the deal: weight loss shots may shrink your appetite, but they don't shrink the reasons you overeat. If you're not working on your mindset and identity, you're just renting results—and the rent is due the minute the meds stop.   I'll break down what the research says, what the Facebook groups aren't telling you, and the powerful truth about emotional eating, identity transformation, and how to finally lose weight in a way that lasts forever. Yes, even in your perimenopause era. What You'll Learn in This Episode: The real reason most women regain weight after stopping GLP-1s (it's not just biology) Why weight loss meds don't fix emotional eating—and what actually does How “Motivational Meltdown” keeps you stuck in a loop (and how to stop it) Why your old identity will sabotage your new body (unless you do this) The simple, repeatable process I teach my clients to stop dieting forever ================================== FEATURED ON THE SHOW / RESOURCES Quiz: What's Your Sneaky Self-Sabotage Pattern? Get my weekly emails: jenniferdent.com/emailclub Website: JenniferDent.com Instagram: @jenniferdentbrown Book your Tea Chat with Jennifer: jenniferdent.com/tea Live Event in Philadelphia: Purchase a Ticket for Cocktails & Clarity: A Wellness Happy Hour The Natural Xpression Medical Spa @thechefkenny

In this episode of Do This, Not That, Jay Schwedelson breaks down what's trending this week—from Instagram's push for carousel posts to summer-themed subject lines that boost open rates. He also covers LinkedIn layoffs, Dick's Sporting Goods buying Foot Locker, and some personal takes on movies and Blake Lively.=================================================Best Moments:(00:34) So basically you should only be posting carousels(01:34) Carousel posts... are increasing average engagement rates... to about 30% higher(02:05) Summer oriented subject lines... have a 22% higher average email open rate(03:15) Your summer starts with this email or hot summer, hotter discounts(03:40) This tool doesn't take summer Fridays(04:19) LinkedIn is facing job cuts(05:12) Do you not then use LinkedIn to find your next job?(05:48) Dick's Sporting Goods bought Foot Locker for $2,400,000,000(06:27) They could be a total of 35% of Nike's sales(06:58) Liberty Mutual's TV spot, the Limu Emu(07:22) They spent... $2,700,000 on that ad this week(07:33) Wegovy's TV spot... $8,700,000 because they're going after some more expensive markets(08:00) Tom Cruise can like jump out of planes(08:28) I do not like these live action versions of cartoons(08:58) This is the sixth film in the Karate Kid whatever(09:39) Sorry, Blake Lively(10:00) She needs to hide. If she just hid for a few months...=================================================Check out our 100% FREE + VIRTUAL EVENTS! ->EVENTASTIC - The worlds LARGEST event about EVENTS! June 5-6 2025Register HERE: https://www.eventastic.com/RegistrationGuru Conference - The World's Largest Virtual EMAIL MARKETING Conference - Nov 6-7!Register here: www.GuruConference.com=================================================Check out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/=================================================AND don't miss out on this awesome FREE upcoming Quick Hit!Marigold: Should I Switch Email Platforms? 5 Truths & Myths!June 24th 11am – 12pm ET.Register HERE: https://www.linkedin.com/events/7325947932031991808/comments/=================================================MASSIVE thank you to our Sponsor, Marigold!!Email chaos across campuses, branches, or chapters? Emma by Marigold lets HQ keep control while local teams send on-brand, on-time messages with ease.Podcast & GURU listeners: 50 % off your first 3 months with an annual plan (new customers, 10 k-contact minimum, terms apply).Claim your offer now at jayschwedelson.com/emma

In today's "Me vs. ChatGPT" episode, Heather tackles the topic of Ozempic and other GLP-1 agonist medications that are now being prescribed to people for weight loss. She uses ChatGPT to help answer the question, "Will Ozempic fix my body image issues?" and is surprised to find ChatGPT to be very informed and aware of the limitations that weight loss has on healing body image issues. This episode will encourage women who are using these medications along with women who are surrounded by others who are using these weight loss drugs. There's no shame or blame if you've chosen to get the shots, but Heather outlines the risks and how, as Christian women, they can lead some of us further into issues like body image idolatry or distract us from our real purpose on this earth. Confidence doesn't come in the form of a weight loss shot, so Heather discusses how healing body image issues requires more than just weight loss. Listen to Heather's other thoughts on Ozempic here: https://omny.fm/shows/compared-to-who/ozempic-and-oprah-have-i-changed-my-mind Learn more about Compared to Who? by visiting: Https://www.improvebodyimage.com The 40-Day Body Image Workbook: https://www.improvebodyimage.com/40-Day-Body-Image-Workbook-Christian The 40 Day Journey (starts week of June 16): https://www.improvebodyimage.com/40-day-challenge Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

Happy Tuesday, y'all! Today we chatted about Andy Cohen's teasing about being a "garbage guzzler" and eating his kids' food off their plates. He jokes about taking Wegovy to make the weight loss easier because everyone is on it. Jeff Lewis has Raven Symone and her wife Miranda on the first hour and Ben and Ronnie from Watch What Crappens Live on the 2nd hour where he's asked about Paige Davis. Grab a drink and let's spend the next hour together! See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Can the Microbiome Replace Ozempic? Two Experts Weigh In on a Radical Theorywith Dr. Gary Pepper & Mary Gocke, RDN, CDN, CHTAre we overlooking the natural power of the gut microbiome in managing weight and metabolism?In this eye-opening conversation, Dr. Gary Pepper — a seasoned endocrinologist — teams up with renowned nutritionist and functional medicine expert Mary Gocke to explore whether the body's own microbiome might one day rival pharmaceutical GLP-1 drugs like Ozempic and Wegovy. From nutritional strategies to protect muscle and bone during weight loss, to the role of akkermansia and polyphenols in boosting natural GLP-1 production, this discussion offers a radically fresh perspective on sustainable metabolic health.Topics covered in this episode include:What GLP-1 medications like Ozempic actually do — and what they don'tWhy weight loss can lead to malnutrition, muscle loss, and even bone density declineHow the gut microbiome — especially Akkermansia muciniphila — may support natural GLP-1 productionThe critical importance of dietary fiber, polyphenols, and prebiotics in metabolic healthHow protein needs shift during rapid weight loss and how to calculate your target intakeEarly evidence for and against the long-term use of GLP-1 drugsThe promising but controversial concept of microdosing and tapering off GLP-1sSimple strategies to protect your body from the side effects of medical weight lossWhy resistant starches (like cooled potatoes and rice) might actually help your microbiomeThe silent risk of osteoporosis from poorly managed weight lossWhether you're currently on a GLP-1 medication, considering one, or exploring natural alternatives, this candid and science-based conversation will equip you with insights not found in mainstream media.

GLP-1 weight loss drugs like Ozempic and Wegovy are being hailed as game-changers, but are they really safe, effective, or sustainable?   Dr. Vanita Rahman joins Chuck Carroll to unpack the data behind these billion-dollar drugs, highlighting alarming side effects, minimal long-term benefits, and industry conflicts of interest. With 129 million Americans eligible and a price tag of $1,600 per month, the stakes are massive.   This episode explores a better way forward—using food as medicine and empowering people with knowledge, not prescriptions.   Plus, Chuck opens up about his own weight loss surgery—and the one thing he wishes he knew beforehand. — — SHOW LINKS — — Ozempic Risks and Letter https://bit.ly/OzempicRisk — — EVENTS — — Exam Room LIVE: Longevity and Muscle Building GreenFare Organic Restaurant Where: Herndon, VA When: May 28, 2025 Tix: https://bit.ly/ERTixGFMay2025 — — — NHA Conference Where: Cleveland, OH When: June 26-29, 2025 Tix & Speakers: https://bit.ly/NHAtix2025 — — — International Conference on Nutrition in Medicine Where: Washington, DC When: August 14-16, 2025 Tix & Speakers: https://www.pcrm.org/icnm — — BECOME AN EXAM ROOM VIP — — Sign up: https://www.pcrm.org/examroomvip — — THIS IS US — — The Exam Room Podcast Instagram: https://www.instagram.com/theexamroompodcast — — — Chuck Carroll Instagram: https://www.instagram.com/ChuckCarrollWLC Facebook: https://www.facebook.com/ChuckCarrollWLC X: https://www.twitter.com/ChuckCarrollWLC — — — Physicians Committee Instagram: https://www.instagram.com/physicianscommittee Facebook: https://www.facebook.com/PCRM.org X: https://www.twitter.com/pcrm YouTube: https://www.youtube.com/user/PCRM Jobs: https://www.pcrm.org/careers — — SUBSCRIBE & SHARE — — 5-Star Success: Share Your Story Apple: https://apple.co/2JXBkpy​​ Spotify: https://spoti.fi/2pMLoY3 — — — Please subscribe and give the show a 5-star rating on Apple Podcasts, Spotify, or many other podcast providers. Don't forget to share it with a friend for inspiration!

Rafal Trzaskowski, the liberal mayor expected to win the first round cleanly only squeaked by. We ask what's at stake in the NATO-front-line country now the second round looks so uncertain. In the new world of weight-loss drugs Wegovy, from Novo Nordisk, has reigned supreme—perhaps not for much longer (9:40). And people really do look—but also act—like their dogs (16:51).Get a world of insights by subscribing to Economist Podcasts+. For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. Hosted on Acast. See acast.com/privacy for more information.

Rafal Trzaskowski, the liberal mayor expected to win the first round cleanly only squeaked by. We ask what's at stake in the NATO-front-line country now the second round looks so uncertain. In the new world of weight-loss drugs Wegovy, from Novo Nordisk, has reigned supreme—perhaps not for much longer (9:40). And people really do look—but also act—like their dogs (16:51).Get a world of insights by subscribing to Economist Podcasts+. For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.

✨ My GLP-1 Girlie group program is opening again at the end of February for enrollment for a 3/2/25 start date.

This week on Fat Science, Dr. Emily Cooper, Andrea Taylor, and Mark Wright break down the latest science behind GLP-1 medications like Ozempic, Wegovy, and Mounjaro. Dr. Cooper shares her decades of expertise on how these drugs work, their evolution, and whether you really have to take them for life. The episode dives deep into the individual factors that impact tapering off, the importance of metabolic signals (like famine and security signals), and why medication is just one piece of the metabolic puzzle. Key Takeaways:GLP-1 medications have advanced significantly, with more convenient dosing and greater effectiveness for many—but responses vary widely from patient to patient.Weight on the scale isn't the only measure; body composition, nutrient levels, and metabolic markers are critical in determining treatment and possible tapering.Not everyone needs to take GLP-1s forever—tapering is possible, but it depends on individual health markers, genetics, and whether metabolic signals are balanced.The future of metabolic health lies in combination therapies that target multiple pathways, not just GLP-1s.Dieting alone disrupts metabolic signals, making professional metabolic medicine and nutrition guidance essential for long-term health.Resources:Connect with Dr. Emily Cooper on LinkedIn.Connect with Mark Wright on LinkedIn.Connect with Andrea Taylor on Instagram.Fat Science is a podcast on a mission to explain where our fat really comes from and why it won't go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn't a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org or dr.c@fatsciencepodcast.com.Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

Did you know that some weight loss medications can help people lose up to 20% of their body weight, comparable to bariatric surgery outcomes? In this episode, I dive into the latest research comparing two major weight loss medications, Wegovy (semaglutide) and Zepbound (tirzepatide), based on findings from the 72-week SURMOUNT-5 trial. I explain how Zepbound led to greater weight loss (about 20.2% vs. 13.7% with Wegovy), possibly due to its dual action on GIP and GLP-1 receptors. Both drugs were generally well tolerated, with similar side effects like nausea and constipation, though Wegovy had slightly more people stop due to GI issues. I also emphasize that while Zepbound may appear more effective, individual needs, such as cardiovascular health or sleep apnea, should guide treatment decisions. Lastly, I remind you that sustainable weight loss requires patience, realistic expectations, and a holistic approach that includes lifestyle changes, not just medication. Tune in to this episode to learn which weight loss medication might be right for you and why your journey to health is more than just the number on the scale.   Episode Highlights: Comparison of Wegovy (semaglutide) and Zepbound (tirzepatide) Average weight loss outcomes and waist circumference changes between both medications Mechanism of action: GLP-1 vs. dual GIP/GLP-1 receptor targeting Side effect profiles and tolerability of both medications FDA approval differences, including cardiovascular risk reduction and sleep apnea treatment Importance of personalized treatment plans and setting realistic weight loss expectations Ongoing research into oral formulations and long-term safety studies Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

The credit rating agency Moody's has stripped the United States of its triple-A credit rating, warning investors about rising levels of government debt and a widening budget deficit. The agency has shifted the US rating down one notch to AA1, while changing its outlook from negative to stable. Novo Nordisk, the company that makes the weight loss drugs Ozempic and Wegovy, is abruptly ousting its chief executive, Lars Fruergaard Jørgensen, over concerns the firm is losing ground in the popular weight-loss drug market. Consumer boycotts of countries and companies are on the rise, with the latest being an Indian tourism boycott of Turkey and Azerbaijan. This comes as some Canadians boycott the US, while others refuse to buy from some specific companies over their policies. We will be joined throughout the programme by Rahul Tandon is joined by two guests on opposite sides of the world: Lori Ann Larocco, senior editor at CNBC Business News in the US, and Peter Ryan, ABC's senior business correspondent in Australia.

Novo Nordisk, the company that makes the weight loss drugs Ozempic and Wegovy, is abruptly ousting its chief executive, Lars Fruergaard Jørgensen, over concerns the firm is losing ground in the popular weight-loss drug market. Consumer boycotts of countries and companies are on the rise, with the latest being an Indian tourism boycott of Turkey and Azerbaijan. This comes as some Canadians boycott the US, while others refuse to buy from some specific companies over their policies. And Rahul Tandon hears about why some private companies in the USA see an opportunity in this rail sector, as there are concerns over the US federal government looking to pull back from supporting rail.

There is an abundance of data on the impact of coffee drinking on health. Dr. Lisa shares the data on the way coffee impacts our risk for premature death, diabetes, depression, heart disease, stroke, Parkinson's disease, dementia, and other health conditions. She also dives in to the impact of coffee on weight loss, of course. And for those taking GLP1 agonists like Wegovy or Ozempic (or GLP/GIP meds like Zepbound or Mounjaro), she reviews the data on coffee and sarcopenia, which is muscle loss.This episode is filled with myth busting surprises about coffee and health. Of course there are downsides to coffee, so if you're pregnant, or you find that coffee causes palpitations, worsening anxiety, or insomnia for you, then it's probably time to rethink your drink or cut down on your coffee. Thanks for listening! If you'd like more support during your SMART weight loss & health focused journey, sign up for our FREE newsletter, or check out our program at: www.SmartWeightLossCoaching.com. We would love to help you reach your happy weight, and transform the way you talk to yourself about your body and the number on the scale. Negative thoughts about yourself don't have to take up so much brain space, and we'd be honored to help you reframe those thoughts. Also…We'd be grateful if you'd follow us and share our podcast with your friends & family. We're here to help you (and those you love) improve your health, live longer, healthier, and lose weight the SMART way! This episode was produced by The Podcast Teacher: www.ThePodcastTeacher.com.

Should Medi-Cal cover the cost of Ozempic for eligible patients? Please Subscribe + Rate & Review KMJ’s Afternoon Drive with Philip Teresi & E. Curtis Johnson wherever you listen! --- KMJ’s Afternoon Drive with Philip Teresi & E. Curtis Johnson is available on the KMJNOW app, Apple Podcasts, Spotify, Amazon Music or wherever else you listen. --- Philip Teresi & E. Curtis Johnson – KMJ’s Afternoon Drive Weekdays 2-6 PM Pacific on News/Talk 580 & 105.9 KMJ DriveKMJ.com | Podcast | Facebook | X | Instagram --- Everything KMJ: kmjnow.com | Streaming | Podcasts | Facebook | X | Instagram See omnystudio.com/listener for privacy information.

Mark Zuckerberg zal geen fijne dag hebben. Die wordt namelijk ingehaald door zijn grote concurrent, TikTok. Moederbedrijf Bytedance ziet de omzet met 20 procent stijgen, ondanks de pogingen van de VS om TikTok op zwart te zetten. Daardoor zou Bytedance eind dit jaar even groot zijn als Zuckerberg's Meta. Christine Lagarde schreef al drie keer geschiedenis: als eerste vrouwelijke financiënminister in Frankrijk, als eerste vrouw die het IMF leidde, en als eerste vrouwelijke baas van de Europese Centrale Bank. Maar daar kan een vierde bladzijde bijkomen. Volgens Bloomberg maakt ze namelijk ook goede kans op het stoeltje van Klaus Schwab bij het World Economic Forum. Gaat ze daarvoor vervroegd vertrekken bij de ECB? Verder gaat het over Novo Nordisk. Beleggers zijn in de war, want de topman vertrekt opeens. Vermoedelijke reden: de farmaceut verliest de competitie om afvalmedicatie van concurrent Eli Lilly. En dat raakt de prijs van het aandeel te hard. Maar de vraag blijft of het wegsturen van de ceo dat gaat oplossen. Je hoort ook wat er aan de hand is bij Coinbase. Het cryptoplatform krijgt twee klappen te verwerken. Iemand perst ze af, maar de toezichthouder denkt ook dat Coinbase zelf beleggers uitperst. En we blikken terug op de week van Donald Trump. Zijn regering sloot plotseling een tijdelijke deal met China. En zelf zat hij ook niet stil, want hij wist honderden miljarden dollars los te peuteren in het Midden Oosten.See omnystudio.com/listener for privacy information.

Before You Take Ozempic, Wegovy, or Mounjaro Listen to This! The challenges for people taking GLP-1s. (1:10) GLP-1s do NOT cause muscle loss. (3:10) The under-muscled epidemic. (5:48) The way GLP-1s work and what they do. (7:45) Obesity vs. under muscled. (11:12) Losing muscle is bad. How do you stop that from happening when on a GLP-1? #1 - Titrate the dose if too strong. Why you should go through a compound pharmacy. (13:30) #2 - Eat high protein. (16:49) #3 - Lift daily. (20:32) #4 - Drink ½ to 1 gallon of water daily. (24:18) #5 - Use essential amino acids, creatine, electrolytes, HMB. (25:42) Related Links/Products Mentioned Special Promotion: MAPS GLP-1 50% off!! ** Code 50OFFGLP1 at checkout ** Visit Seed for an exclusive offer for Mind Pump listeners! **Promo code 25MINDPUMP at checkout for 25% off your first month's supply of Seed's DS-01® Daily Synbiotic** Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss? Visit Transcend for this month's exclusive Mind Pump offer! ** 25% off all GLP-1s – This includes the GLP-1 probiotic which people can order through their specialist. ** Mind Pump #2360: What You Need to Know About GLP-1 With Dr. Tyna Moore Mind Pump #2110: Ozempic the Miracle Fat Loss Peptide: The Truth With Dr. William Seeds Mind Pump #2410: How to Maximize Fat Loss & Preserve Muscle on GLP-1s (Introducing MAPS GLP-1) Mind Pump #2432: The Truth About Essential Amino Acids with Angelo Keely HMB benefits, dosage, and side effects - Examine Mind Pump Podcast – YouTube Mind Pump Free Resources    

I've been waiting a long time to release this one. Dr. Tyna Moore is someone I've wanted to bring on the show because her take on GLP-1s like Ozempic, Wegovy, and Tirzepatide is so refreshingly honest and grounded in both science and clinical experience. There's so much confusion, fear, and flat-out propaganda around these peptides, and today, we clear the air. We talk about how GLP-1 agonists work not just as weight-loss drugs but as powerful regenerative and neuroprotective tools. Yes, they help you stop obsessively thinking about food. Yes, they can dramatically help with insulin resistance. But the real story? These peptides might help heal your metabolism for good. Tyna doesn't hold back. We unpack the massive industry bias against these drugs, the obesity stigma nobody wants to talk about, and the misinformation that's keeping people sick, scared, and stuck. If you've ever wondered whether peptides are a shortcut or a real solution, this episode lays it all out. And if you're using these tools without lifting weights, optimizing sleep, eating real food, and managing your circadian rhythm? You're setting yourself up for muscle loss and disappointment. GLP-1s are not a miracle. They're a tool. But if you use them the right way, they just might change your life.   "I think there's magic in time under treatment with this peptide. I think the longer somebody's on it, the more long-term healing and regenerative benefits we ultimately get." ~ Dr. Tyna Moore   In This Episode: - GLP-1s explained: Ozempic, Wegovy, Mounjaro  - Benefits beyond weight loss: cardiovascular, neurological, regenerative - Why the pushback against Ozempic? - Muscle loss myths - Addressing other common myths and side effects - The emotional side of weight loss - The metabolic dysfunction epidemic and why it starts early - Proper GLP-1 dosing strategies: "low and slow" approach - Dr. Tyna's free resources and education courses For more, visit https://myersdetox.com    Heavy Metals Quiz: Find out your toxicity score and receive a free video series on detoxification at https://heavymetalsquiz.com    Resources Mentioned: Puori PW1 Protein Powder: Get 20% off with code WENDY at https://puori.com/wendy  Tru Energy Skincare: Get a special deal at https://trytruenergy.com/wendy  Organifi Collagen: Save 20% with code MYERSDETOX at https://organifi.com/myersdetox  Fresh Pressed Olive Oil: Get a $39 bottle for just $1 to cover shipping at https://getfreshwendy.com    About Dr. Tyna Moore: Dr. Tyna Moore is an expert in holistic regenerative medicine and resilient metabolic health with nearly 30 years in the medical field. As both a licensed naturopathic physician and chiropractor, she brings a comprehensive perspective to metabolic health, drawing from traditional and alternative medicine. Dr. Moore has made waves with her open-minded exploration of peptides like semaglutide (Ozempic) as tools for healing and longevity. She champions medical autonomy and individual accountability while hosting The Dr. Tyna Show podcast and speaking internationally. Learn more at: https://drtyna.com    Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

Howie and Harlan are joined by James Dodington, a Yale pediatric emergency medicine physician and an expert in community-based violence prevention. Harlan reports on the remarkable financial results and sometimes questionable science of Hims & Hers Health; Howie discusses UnitedHealthcare's faltering stock price in the face of anger over aggressive care denial and a lawsuit from shareholders. Links: Oscar Health and Hims & Hers “Oscar Health Profits Eclipse $275 Million As Obamacare Enrollment Soars” “Hims & Hers Health Revenue Jumps, But Outlook Disappoints” “Hims & Hers' Q1 revenue doubles to $586M, boosted by growth in weight loss business” “Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers” “They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.” “EU drugs regulator confirms suicidal thoughts as side effect of hair loss drug” “Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines” “FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products” James Dodington Health & Veritas Episode 81: Joseph Sakran: Confronting Gun Violence Health & Veritas Episode 77: Megan Ranney: What's Next for Public Health? “Children and teens are more likely to die by guns than anything else” “U.S. Surgeon General Issues Advisory on the Public Health Crisis of Firearm Violence in the United States” “New Report Highlights U.S. 2022 Gun-Related Deaths: Firearms Remain Leading Cause of Death for Children and Teens, and Disproportionately Affect People of Color” James Dodington: “Rural Versus Urban Hospitalizations for Firearm Injuries in Children and Adolescents” “Disparities in Pediatric Mental and Behavioral Health Conditions” “Special Report: Dean Megan Ranney Brings a Public Health Approach to the Country's Gun Violence Epidemic” “Gun Violence Is a Public Health Crisis—But Hospital-based Intervention Programs Can Help Break the Cycle” “Implementation of an emerging hospital-based violence intervention program: a multimethod study” UCSF Wraparound Project: The Public Health Model for Violence Prevention “Just Listen” Firearm Injury Prevention at the Yale School of Public Health “11 Years After Sandy Hook—A New Path Toward Healing and Hope” Nelba Márquez-Greene's Shared Humanity Podcast 4-CT:Violence Intervention and Prevention “Cash Pilot Targets Violence Victims” “How unrestricted cash aid is transforming violence intervention in Connecticut” “Yale undergraduate team takes first place in national health policy competition” UnitedHealthcare “UnitedHealth CEO Is Out, Sending Shares Plummeting” “UnitedHealthcare sued by shareholders over reaction to CEO's killing” UnitedHealth Shareholder Lawsuit “UnitedHealth's string of setbacks, from exec murder to cyber attack” “Zepbound Patients Fear Losing Coverage After CVS Deal for Wegovy” “Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs”  

Over the last few decades, a lot of products and technologies have promised to disrupt the diets and food buying habits of the world's consumers. But nothing has made true on that promise quite like the emergence of GLP-1 weight-loss drugs like Ozempic and Wegovy. These (as of now) injectables are changing the way people– and their households– eat and shop, and CPG companies, quick serve food brands, and others are already seeing a marked decline in purchasing in the months since these drugs have gone mainstream. Given the speed with which people are adopting these treatments, and how fast the therapy affects their diets and choices, many in the food and ag sectors have been caught flat footed by a dramatic change in preferences among 10% (and growing) of consumers. Who will be the winners and losers?To tell us more about what the future might hold for ag and food alike, we're joined this week by Mary Shelman, Founder at the Shelman Group. For more information and resources, visit our website. The information in this post is not investment advice or a recommendation to invest. It is general information only and does not take into account your investment objectives, financial situation or needs. Before making an investment decision you should seek financial advice from a professional financial adviser. Whilst we believe the information is correct, we provide no warranty of accuracy, reliability or completeness.

GLP-1 RA medications like Ozempic and Wegovy are transforming more than waistlines—they're reshaping beauty standards and creating new challenges and opportunities in skin care. Rapid weight loss can lead to loose skin, facial volume loss, and dehydration, making professional esthetics care more important than ever. This episode of ASCP Esty Talk explores how skin care pros can support clients through these changes with treatments that restore, tighten, and celebrate their evolving bodies. ASCP Esty Talk with hosts Ella Cressman and Maggie Staszcuk   Produced by Associated Skin Care Professionals (ASCP) for licensed estheticians, ASCP Esty Talk is a weekly podcast, hosted by licensed estheticians, Ella Cressman, ASCP Skin Deep Magazine contributor, and Maggie Staszcuk, ASCP Program Director. We see your passion, innovation, and hard work and are here to support you by providing a platform for networking, advocacy, camaraderie, and education. We aim to inspire you to ask the right questions, find your motivation, and give you the courage to have the professional skin care career you desire.  About Ella Cressman:  Ella Cressman is a licensed esthetician, certified organic formulator, business owner, ingredient junkie, and esthetic cheerleader! As an educator, she enjoys empowering other estheticians and industry professionals to understand skin care from an ingredient standpoint rather than a product-specific view.  In addition to running a skin care practice, Cressman founded a comprehensive consulting group, the HHP Collective, and has consulted for several successful skin care brands.    Connect with Ella Cressman:  Website: www.hhpcollective.com  LinkedIn: linkedin.com/in/ella-cressman-62aa46a    About Maggie Staszcuk:  Maggie Staszcuk serves as the Program Director for ASCP and is the cohost of ASCP Esty Talk podcast. With over 18 years' experience in the esthetics industry, her diverse background includes roles in spa management, spa and med-spa services, and esthetics education. Since becoming a licensed esthetician in 2006, she carries a range of certifications in basic and advanced esthetics. Maggie is dedicated to equipping estheticians with the knowledge and resources they need to thrive in their careers.   Connect with Maggie Staszcuk:  P: 800.789.0411 EXT 1636  E: MStaszcuk@ascpskincare.com    About our Sponsors:   The popular and revolutionary LAMPROBE utilizes radio and high-frequency technology to treat a wide variety of Minor Skin Irregularities™ (MSI)—non-invasively—with instantaneous results. Common conditions treated by the LAMPROBE include: vascular MSI, such as cherry angiomas; dilated capillaries; sebaceous MSI, including cholesterol deposits and milia; and hyperkerantinized MSI, such as keratoses and skin tags.   The LAMPROBE uniquely assists modern, capable, and skilled skin care practitioners to do their work more effectively and with greater client and professional satisfaction. Setting standards in quality, education, and training, the LAMPROBE has become an essential tool enabling skin care practitioners around the world to offer new revenue-enhancing and highly in-demand services.   Website: www.lamprobe.com   Email: info@lamskin.com   Phone: 877-760-2722   Instagram: www.instagram.com/lamprobe   Facebook: www.facebook.com/theLAMPROBE   TiZO Mineral Sunscreens set the standard for aesthetic elegance with tinted and non-tinted formulas for use on virtually all skin types and tones. Our name reflects our commitment: TIZO = Titanium dioxide + Zinc Oxides. All TiZO products are reef-friendly and 100% free of chemical sunscreens, dyes, fragrances, gluten, phthalates, and parabens.  TiZO Photoceutical Skincare is the perfect partner to our sunscreens in the fight against photoaging. These silky, elegant products address tone, texture and hydration while helping to prevent further damage. From our flagship TiZO3 Primer/Sunscreen SPF 40 to our gentle Ultra Zinc formulations to our NEW Advanced Vitamin C+E Serum with Bakuchiol, TIZO has the ideal selection of products to Protect, Repair, and Revitalize skin.  Website: https://tizoskin.com/  Facebook: @tizoskin  Pinterest: @tizoskin  Instagram: @tizoskin  YouTube: @tizoskin     Massage Envy is a national franchisor and does not independently own or operate any of the Massage Envy franchised locations nationwide. The Massage Envy franchise network, through its franchise locations, is the leading provider of massage services. Founded in 2002, Massage Envy now has approximately 1,100 franchise locations in 49 states that have together delivered more than 200 million massages and skin care services. Website: www.massageenvy.com/careers/career-areas/esthetician  Facebook: @MassageEnvyCareers LinkedIn: @MassageEnvy   About Associated Skin Care Professionals (ASCP):    Associated Skin Care Professionals (ASCP) is the nation's largest association for skin care professionals and your ONLY all-inclusive source for professional liability insurance, education, community, and career support. For estheticians at every stage of the journey, ASCP is your essential partner. Get in touch with us today if you have any questions or would like to join and become an ASCP member.  Connect with ASCP:  Website: www.ascpskincare.com  Email: getconnected@ascpskincare.com  Phone: 800-789-0411  Facebook: facebook.com/ASCPskincare  Instagram: @ascpskincare   

Still Not Sure What's Behind Your Hormone Symptoms? Take the first step to balance your hormones naturally with my FREE Hormone Symptom Profile Assessment: https://bit.ly/takemyhormonequiz Weight won't budge? Want to lose 10 (or 20) pounds before summer so you can feel good in your skin again—and without hiding under a caftan.

Saudi Arabia rolled out the red carpet for President Trump. It was a celebration between the two countries as President Trump brought back the respect and reverence for America as he took the stage with Crown Prince and Prime Minister Mohammed bin Salam. The Saudis pledged to invest $600 Billion into the U.S. economy, including $142 Million in American made military equipment plus multi-billion dollar deals with Amazon, Oracle and A.M.D. With President Trump's "most favored nation" policy on drug prices, media outlets, funded by pharma, are downplaying the impact it will have on the consumer. Senator Roger Marshall walks us through PBMs (Pharmacy Benefit Manager) in the pharmaceutical market and how they profit as middlemen between drug manufacturers and healthcare companies. PMBs are the reason a drug like Wegovy is over $1,000 a month in the U.S. and $59 in Germany. Senator Marshall unpacks the GOP budget bill, including his championing of no tax on overtime wages. As an obstetrician, Dr. Marshall has known President Trump's cabinet to make America healthy again and is confident they can get the job done in removing processed foods and chronic diseases. Featuring; Senator Roger Marshall U.S. Senator | Kansas https://www.marshall.senate.gov/ Today's show is brought to you by these amazing sponsors: Wired 2 Fish Coffee Do you want to drink coffee from the finest coffee beans in the world? Wired 2 Fish sources directly from Mexico and Guatemala to bring you the freshest arabica coffee beans in the world. Wired 2 Fish cares so much about the earth that they give back 25% of their net profits to faith-based organizations and clean water initiatives. If you're a coffee lover and want to support a great company doing great work head to https://www.wired2fishcoffee.com/ use code: WECARE for 15% off your first order. Delta Rescue Delta Rescue is one the largest no-kill animal sanctuaries. Leo Grillo is on a mission to help all abandoned, malnourished, hurt or suffering animals. He relies solely on contributions from people like you and me. If you want to help Leo to continue his mission of running one of the best care-for-life animal sanctuaries in the country please visit Delta Rescue at: https://deltarescue.org/ Beam For a limited time got 40% of Beam's Dream Powder. Dream Powder with Reishi, Magnesium, L-Theanine, Apigenin and Melatonin to help you fall asleep, stay asleep, and wake up refreshed. Just head to https://shopbeam.com/SPICER for 40% off. ------------------------------------------------------------- 1️⃣ Subscribe and ring the bell for new videos: https://youtube.com/seanmspicer?sub_confirmation=1 2️⃣ Become a part of The Sean Spicer Show community: https://www.seanspicer.com/ 3️⃣ Listen to the full audio show on all platforms: Apple Podcasts: https://podcasts.apple.com/us/podcast/the-sean-spicer-show/id1701280578 Spotify: https://open.spotify.com/show/32od2cKHBAjhMBd9XntcUd iHeart: https://www.iheart.com/podcast/269-the-sean-spicer-show-120471641/ 4️⃣ Stay in touch with Sean on social media: Facebook: https://facebook.com/seanmspicer Twitter: https://twitter.com/seanspicer Instagram: https://instagram.com/seanmspicer/ 5️⃣ Follow The Sean Spicer Show on social media: Facebook: https://facebook.com/seanspicershow Twitter: https://twitter.com/seanspicershow Instagram: https://instagram.com/seanspicershow Learn more about your ad choices. Visit megaphone.fm/adchoices

Joe's Petition + All My Links: https://linktr.ee/manonthemounjaro

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended alongside a controlled diet and regular physical activity.  

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about President Trump’s new pick for surgeon general, Zepbound beating Wegovy for weight loss in the first head-to-head trial of blockbuster drugs, and measles cases still rising.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about President Trump’s new pick for surgeon general, Zepbound beating Wegovy for weight loss in the first head-to-head trial of blockbuster drugs, and measles cases still rising.

Stock markets rally as US and China agree to slash tariffs for at least 90 days. Also: Kurdish PKK militants end armed struggle against Turkey and Mounjaro and Wegovy go head to head in weight loss trial.

Tirzepatide is more effective for weight loss than semaglutide.Cost-effectiveness is crucial in prescribing weight loss medications.Patients with severe obesity should receive more expensive medications for better outcomes.Both medications show significant benefits for obesity-related conditions.Long-term studies indicate sustained weight loss with both drugs.Gender differences affect weight loss outcomes with these medications.Safety profiles show tirzepatide may be better tolerated than semaglutide.The need for affordable drug pricing is emphasized.Clinical benefits extend beyond weight loss to include metabolic health.Future studies are needed to confirm cardiovascular benefits of tirzepatide.Click here to see the studyClick here to join Dr. Spencer's new online clinic

In today's episode of the Natalie Tysdal Podcast, we're talking about one of the most requested and hottest topics in women's health: weight loss, hormones, and the latest breakthroughs in obesity medicine. Natalie is joined by Dr. Megan Garcia-Webb—primary care physician, board-certified in obesity and lifestyle medicine, and life coach—to demystify weight loss medications like Ozempic, Wegovy, and others that are making waves. You'll discover what makes these new GLP-1 injectable drugs so revolutionary, why they work so well for weight loss (especially for women over 40 dealing with hormonal changes), and the crucial role of mindset and coaching in sustainable results. Dr. Garcia-Webb explains why medical supervision is non-negotiable, how to safely manage side effects, and the red flags to watch out for when considering medication from less familiar sources. You'll learn: The science behind GLP-1 medications and how they help with significant weight loss   Why mindset, goal-setting, and self-compassion are key for lasting change   The most common side effects and how to avoid serious risks with proper management   Why you shouldn't go it alone: the importance of finding a qualified medical professional   How these medications might be useful in the future for issues beyond weight, like addiction and inflammation   The right way to combine healthy habits, nutrition, exercise, and listening to your body, with medication for best results If you're considering weight loss meds, want clarity about side effects and insurance coverage, or just need inspiration to start your health journey over 40, this episode will give you the inside scoop you need to make smart, empowered decisions. The FREE Gut Reset Plan: https://www.natalietysdal.com/GutReset Seeking Health Vitamins and Supplements: https://crrnt.app/SEEK/NgmAZXqO

✨ My GLP-1 Girlie group program is opening again at the end of February for enrollment for a 3/2/25 start date.

La familia Real de Catar regaló a Donald Trump un lujoso avión valorado en más de 400 millones de dólares.En otras noticias: Con una nueva orden ejecutiva el presidente Trump espera reducir entre el 30% y 80% el precio de los medicamentos recetados. ¿Qué tan viable es?El Departamento de Seguridad Nacional inició una investigación para verificar si el condado de Los Ángeles proporcionó desde el 2021beneficios a personas indocumentados.Un juez federal autorizó que IRS comparta información fiscal confidencial con las autoridades migratorias para ayudar a localizar y deportar a inmigrantes indocumentados bajo investigación criminal.Hamás liberó al soldado estadounidense-israelí Edan Alexander.Comenzó el juicio contra Sean Diddy Combs en Nueva York en medio de escabrosas declaraciones. 

Os medicamentos injetáveis para emagrecimento, conhecidos como “canetas emagrecedoras”, incluindo Ozempic, Wegovy, Saxenda, Mounjaro e similares vinham sendo vendidos livremente no Brasil, sem a necessidade de prescrição médica. Mas isso vai mudar.A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou uma nova regra para a venda desses medicamentos, que só poderá ser feita mediante apresentação de receita médica em duas vias, sendo que uma delas ficará retida na farmácia - procedimento semelhante ao já adotado para antibióticos.Neste episódio, conversamos sobre as indicações desses medicamentos, seus efeitos colaterais e a importância do acompanhamento médico para o uso correto.Links relacionados:Tirzepatide as Compared with Semaglutide for the Treatment of ObesityComida Sem Filtro #88 – Injetáveis Para EmagrecerComida Sem Filtro #146 – Ozempic: Como Evitar O Reganho De Peso?Comida Sem Filtro #125 – Efeito Ozempic Na Indústria De AlimentosEstamos no Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Souto⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sari Fontana⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Para ser avisado sobre cada novo episódio e receber os links das matérias mencionadas e as referências bibliográficas por e-mail, cadastre-se gratuitamente em ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drsouto.com.br/podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Adquira seu livro - UMA DIETA ALÉM DA MODA: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (também na versão Kindle)"Dance of the Sugar Plum Fairy"Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 3.0⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://creativecommons.org/licenses/by/3.0/⁠

Have you ever said "Nothing tastes as good as skinny feels"? If you were around in the 80's and 90's, you likely either said this or have heard it before, thanks to some notorious fad diet programs out there. This week we are discussing the "Skinny Tok" trend that is coming back full circle and bringing with it all of the diet culture sayings and trends that we are working so hard to leave behind. There is a harmful narrative and focus in social media about being skinny again and its hard to ignore the correlation between this type of messaging and the popularity of weight loss drugs.We also rant and rave about peptide supplements and MLM companies trying to capitalize on GLP-1 drugs like Wegovy, Semaglutide, Terzepetide, and more - further proving that diet culture and the supplement industry won't rest until they squeeze every last penny out of you.Buckle up and tune in because we've got some things to say!Subscribe, stack, and save with Cured Nutrition! Never run out of your supply of Serenity or Flow gummies by subscribing and receive 20% off! In addition to that, you can stack your favorite bundle (we love the Harmony bundle!) to receive an additional 10% off. ⁠⁠Click here⁠⁠ for huge savings and don't forget to add our code 'CTC' for additional savings! Thank you Cured Nutrition for sponsoring this episode!Right now you can become an annual member of our Patreon and receive 30% off! Join now for monthly workouts, challenges, recipes, and to become part of the Cut The Crap Community! https://www.patreon.com/cutthecrappodcast⁠⁠⁠Visit our website to learn more about us, contact us, inquire about collaborating with us and more: ⁠⁠⁠https://www.cutthecrappod.com/⁠⁠⁠Follow us on Instagram: @cutthecrapwithbethandmattLike this episode? Why not share it with a friend!Send us a DM on Instagram to let us know what you think of this one, and with episode ideas! If we use your comment or suggestion, we'll give you a shoutout on the podcast!

Dave Knapp is a patient-turned-advocate in the field of GLP1 medications, obesity, and type 2 diabetes. He is the creator of "On the Pen," a fast-growing media platform that serves as a hub for breaking news and advocacy related to these pivotal areas. Through his extensive research and engagement with the subject, Dave has built a thriving online community focused on increasing awareness and access to life-changing GLP1 treatments. His insightful work has been featured in major outlets including Fortune, Bloomberg, and Yahoo Finance. Dave is also the author of the book "Decoding GLP1," offering a comprehensive guide to these medications. He resides in Washington, D.C., where he continues his advocacy work.Please learn more about David Knapp at www.GLPbook.comIn this episode of Mr. Biz Radio, Ken" Mr.Biz" Wentworth delves into the subject of GLP1 medications, obesity, and type 2 diabetes with guest Dave Knapp, a leading advocate in the field. The discussion revolves around how these medications are transforming lives by providing new treatment avenues for those battling obesity and type 2 diabetes. Dave shares his personal journey from being a patient to becoming a dedicated advocate, offering listeners a unique insider's perspective on the topic.Dave Knapp explains the science behind GLP1 medications, highlighting their role in mimicking naturally occurring hormones that impact insulin secretion and appetite control. He dispels common myths, emphasizing the long-standing presence of these drugs in the medical field. The conversation also covers the side effects associated with GLP1s, the variations in their effectiveness based on individual health profiles, and provides actionable insights into optimizing their use for better health outcomes.Key Takeaways:-These medications mimic naturally occurring hormones that are crucial in appetite control and insulin secretion, offering hope for patients with obesity and type 2 diabetes.-Dave Knapp turned to advocacy after his personal battle with obesity and type 2 diabetes, culminating in the creation of the "On the Pen" media platform.-A major misconception is that GLP1 medications are only for diabetes. They are also prescribed for obesity management.-New generations of GLP1 drugs like Mounjaro and Wegovy show substantial promise with less muscle mass loss when combined with lifestyle changes.-Dave Knapp's book "Decoding GLP1" provides invaluable information from a patient's perspective for those seeking to understand these medications better.

Another key Fed decision on deck, as the recent stock market bounce loses steam. What to expect from Fed Chair Jerome Powell, and what it will mean for the market's next move. Plus Earnings season in full swing, and Wegovy-maker Novo Nordisk is ready to report. Why one top healthcare analyst is eyeing potential tariff risks and political overhang as a headwind for the whole weight loss drug space.Fast Money Disclaimer

In this week's episode of The Wellness Scoop, we're diving into some of the biggest shifts and studies shaping the future of health and wellness. We look at a powerful new study showing how switching to a traditional diet for just two weeks can reduce inflammation and boost immunity — without supplements or complex protocols. It's part of a growing movement back to simpler, seasonal, plant-forward eating. We also explore the link between high blood pressure and dementia risk. A large-scale trial found that addressing cardiovascular health in midlife — through medication and lifestyle changes — could reduce dementia risk by 15%. We break down what that means in practical terms. WW (formerly WeightWatchers) is reportedly heading for bankruptcy, and it's raising big questions about the future of diet culture. With the rise of GLP-1 medications like Ozempic and Wegovy, we're seeing a shift toward science-backed, compassionate health strategies that move away from guilt, tracking, and restriction. Rhi brings back a fascinating study on daytime napping and brain health — showing that a short daily nap may help slow brain ageing and preserve brain volume. Plus, we look at the wellness trends forecast for 2025 — from high-protein breakfasts and mastic gum to brain flossing, okra water, and metabolic tracking tools. What's worth paying attention to, and what's just another layer of over-optimising? Recommendations: Batch-cooking quinoa! A real time saver for when you're having a busy week Sparkling water, super tasty and without additives. Panorama's investigation into baby food pouches - worth watching ahead of the discussion next week Live Show Tickets - ⁠⁠⁠⁠⁠https://cadoganhall.com/whats-on/the-wellness-scoop-with-ella-mills-and-rhiannon-lambert/⁠⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices